TTMITTM Technologies, Inc.

$121.03+132% 1Y

Is the business good?

Good

A genuinely good business: 7 of 9 health tests passed, earnings fully cash-backed (1.1×), and margins widening.

3 good, 1 neutral
Fundamental health (F-score)7 / 9SEC EDGAR · Dec 29, 2025

High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash1.08×derived · Jun 29, 2026

Operating profit is fully backed by cash. Conversion is worsening vs a year ago.

Margin direction, 3 years+3.2 pts

Positive operating leverage, operating profit is growing faster than sales, so margins widen as the business scales.

Where ROE comes from5% ROA

A balanced mix of margins, efficiency, and leverage. ROE 10% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbottom 9% of the market
Leverage (Debt/EBITDA)middle of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is TTMI?

TTM Technologies, Inc. earns 11% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.

11%

Return on invested capital · cost of capital 9.0% · 2.0 points above what the capital costs: growth creates value

Operating margin
9.9%

Operating margin · Electronic Components median 8.4% · 12 months to Q2 2026

Cash conversion
1.08×

Cash conversion · 1.87× a year ago · operating cash flow covers the operating profit after tax

Share count, year on year
+2.6%

Share count, year on year · shareholders own a smaller slice than a year ago

Operating margin by fiscal year
YearOperating margin
FY20201.3%
FY20215.6%
FY20228.4%
FY20231.9%
FY20244.8%
FY20259.1%
Details›
Gross margin12 months to Q2 2026
21%
Operating margin12 months to Q2 2026
9.9%
Net margin12 months to Q2 2026
7.0%
Free cash flow margin
−0.45%
R&D as % of revenue
0.88%
Revenue, trailing twelve months
$3.38B
Free cash flow, trailing twelve months
−$15M
Net income, trailing twelve months
$237M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
11%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.